Security key
68622P109
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC)
CUSIP: 68622P109
Q1 2021 13F Holders as of 31 Mar 2021
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 105,956,500
- Total 13F shares
- 35,685,685
- Share change
- +3,077,832
- Total reported value
- $874,284,848
- Price per share
- $24.50
- Number of holders
- 82
- Value change
- +$71,774,159
- Number of buys
- 49
- Number of sells
- 20
Report period
Q1 2021
Institutions
82
Top holders
10
ORIC full security history
Newer quarter: Q2 2021
Previous quarter: Q4 2020
Oric Pharmaceuticals, Inc. SEC filings
Oric Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68622P109
Recent filing periods:
Top shareholders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
5.1%
|
5,452,347
|
$184,562,000 | — | 31 Dec 2020 | |
| Column Group LLC |
13F
|
Company |
4.5%
|
4,768,181
|
$161,403,000 | — | 31 Dec 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.9%
|
3,092,218
|
$104,672,000 | — | 31 Dec 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.8%
|
2,921,967
|
$98,909,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.8%
|
1,878,908
|
$63,602,000 | — | 31 Dec 2020 | |
| Euclidean Capital LLC |
13F
|
Company |
1.3%
|
1,400,435
|
$47,405,000 | — | 31 Dec 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
1%
|
1,100,293
|
$37,245,000 | — | 31 Dec 2020 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.99%
|
1,052,879
|
$35,640,000 | — | 31 Dec 2020 | |
| Invus Financial Advisors, LLC |
13F
|
Company |
0.95%
|
1,007,575
|
$34,106,000 | — | 31 Dec 2020 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.85%
|
898,061
|
$30,399,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.82%
|
867,551
|
$29,366,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.81%
|
853,806
|
$28,901,000 | — | 31 Dec 2020 | |
| Sloan Kettering Cancer Center Memorial |
13F
|
Individual |
0.57%
|
602,272
|
$20,387,000 | — | 31 Dec 2020 | |
| Casdin Capital, LLC |
13F
|
Company |
0.57%
|
601,515
|
$20,361,000 | — | 31 Dec 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.55%
|
584,000
|
$19,768,000 | — | 31 Dec 2020 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.49%
|
523,480
|
$17,720,000 | — | 31 Dec 2020 | |
| EMERALD ADVISERS, LLC |
13F
|
Company |
0.49%
|
522,302
|
$17,680,000 | — | 31 Dec 2020 | |
| EMERALD MUTUAL FUND ADVISERS TRUST |
13F
|
Company |
0.46%
|
488,234
|
$16,527,000 | — | 31 Dec 2020 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.41%
|
430,000
|
$14,556,000 | — | 31 Dec 2020 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
0.39%
|
413,061
|
$13,982,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.34%
|
359,043
|
$12,154,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
314,500
|
$10,645,000 | — | 31 Dec 2020 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
252,910
|
$8,561,000 | — | 31 Dec 2020 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.23%
|
248,898
|
$8,425,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
237,047
|
$8,024,000 | — | 31 Dec 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
0.19%
|
200,000
|
$6,770,000 | — | 31 Dec 2020 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.17%
|
182,200
|
$6,167,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
109,713
|
$3,714,000 | — | 31 Dec 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.1%
|
101,862
|
$3,448,000 | — | 31 Dec 2020 | |
| Artal Group S.A. |
13F
|
Company |
0.09%
|
100,000
|
$3,385,000 | — | 31 Dec 2020 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.09%
|
97,194
|
$3,290,000 | — | 31 Dec 2020 | |
| Laurion Capital Management LP |
13F
|
Company |
0.09%
|
96,536
|
$3,268,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
73,731
|
$2,496,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
67,996
|
$2,302,000 | — | 31 Dec 2020 | |
| Asymmetry Capital Management, L.P. |
13F
|
Company |
0.06%
|
67,210
|
$2,275,000 | — | 31 Dec 2020 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.05%
|
53,000
|
$1,789,000 | — | 31 Dec 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.05%
|
49,455
|
$1,674,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
40,600
|
$1,374,000 | — | 31 Dec 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
40,435
|
$1,369,000 | — | 31 Dec 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.03%
|
34,685
|
$1,174,000 | — | 31 Dec 2020 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
33,559
|
$1,136,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
31,209
|
$1,056,000 | — | 31 Dec 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.03%
|
27,694
|
$937,000 | — | 31 Dec 2020 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.03%
|
26,841
|
$909,000 | — | 31 Dec 2020 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
24,800
|
$839,000 | — | 31 Dec 2020 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
21,992
|
$744,000 | — | 31 Dec 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.02%
|
21,322
|
$722,000 | — | 31 Dec 2020 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
18,400
|
$623,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
17,822
|
$603,000 | — | 31 Dec 2020 | |
| BEACON INVESTMENT ADVISORY SERVICES, INC. |
13F
|
Company |
0.02%
|
17,556
|
$594,000 | — | 31 Dec 2020 |
Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q1 2021
As of 31 Mar 2021,
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) was held by
82 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,685,685 shares.
The largest 10 holders included
FMR LLC, The Column Group LLC, EcoR1 Capital, LLC, ORBIMED ADVISORS LLC, BlackRock Inc., STATE STREET CORP, Point72 Asset Management, L.P., VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, and JENNISON ASSOCIATES LLC.
This page lists
82
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
76
Q1 2021 holders
82
Holder diff
6
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.